89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL)
Status:
Recruiting
Trial end date:
2022-09-11
Target enrollment:
Participant gender:
Summary
The main purposes of this study include:
Looking at the way the body absorbs, distributes, and gets rid of 89Zr-DFO-REGN3767
Finding the best dose amount of 89Zr-DFO-REGN3767
Finding the best time for PET scanning after injection of 89Zr-DFO-REGN3767